Environmental Sustainability, Drug Repurposing, and Pricing. Pathways to align Value, Access, and Policy

September 25 | 17:00

Healthcare contributes 4–5% of global greenhouse gas emissions, with traditional drug development consuming vast amounts of resources. Repurposing existing medicines offers a unique opportunity to reduce this environmental footprint while improving patient access and affordability. Yet, current pricing and regulatory frameworks often undervalue repurposed drugs and disincentivize investment.

Join this session to explore real-world examples of how drug repurposing can advance both sustainability and health equity. We’ll also discuss why policy and pricing reforms, such as flexible reimbursement models and integrating environmental criteria into health technology assessments, are essential to unlocking the full ecological and societal value of repurposing.